Proposed amendments to Medical Devices Rules

One line

The Health Ministry proposed amendments to the Medical Devices Rules, 2017 to simplify compliance while maintaining quality and safety oversight.

Summary

Medical devices range from low-risk products to implants and life-support equipment. Risk-based regulation should support innovation and access without weakening clinical evidence, manufacturing quality, or post-market surveillance.

PYQ pattern

UPSC can link health regulation with domestic manufacturing, patient safety, affordability, and innovation.

Core notes

Device regulation commonly classifies products by risk.
Quality-management systems govern design, production, traceability, and corrective action.
Post-market surveillance can identify failures not visible before approval.
Ease of doing business should focus on predictable, digital, and proportionate procedures.

Prelims lens

Medical devices are regulated separately from, though alongside, medicines.
Risk classification affects the level of regulatory scrutiny.
An implant and a simple non-invasive device need not face identical requirements.

MCQ 1

Risk-based device regulation means:

A. Scrutiny is calibrated to potential harm
B. Every device has identical requirements
C. High-risk implants need no evidence
D. Post-market surveillance is unnecessary

Reveal answer

A

Higher-risk products generally require stronger evidence and oversight.

MCQ 2

Post-market surveillance is useful because it:

A. Detects safety or performance problems during real-world use
B. Replaces manufacturing standards
C. Ends traceability
D. Applies only before approval

Reveal answer

A

Continued monitoring can reveal rare or context-specific problems.

Mains

Question, 10 marks, 150 words: How should India balance medical-device innovation with patient safety?

Approach:

Explain risk-based regulation.
Discuss evidence, quality systems, and surveillance.
Note compliance and access concerns.
Suggest predictable approvals and recall systems.